We’re living in the era of big data and it’s opening doors for AI-driven multiomics and health. Biomedical information is being generated extremely quickly. Approximately 40 exabytes (or one billion ...

These resources make recommendations for achieving good data governance and trustworthy systems of data storage and sharing. They set out for researchers – or anyone needing up to date overviews – the ...

The rapid development, approval and roll out of multiple vaccines against SARS-CoV-2, the virus that causes COVID-19, is an impressive achievement for science and healthcare. The virus genome was ...

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021. It has been ten years since the World Health ...

With the recent launch of its infectious diseases strategy, Public Health England (PHE) has outlined is ambitions for the next five years in terms of its core mission “to prevent, detect, respond to ...

Integration of polygenic scores (PGS) into clinical practice requires robust, validated mechanisms to generate these scores. A consistent message in our reports has been that to deliver PGS-based ...

A set of consensus statements on the use of biomarkers in cancer research and treatment were released this month. They aim to accelerate the discovery, development, and adoption of biomarkers into the ...

The European Health Data Space Regulation has arrived but will its mandatory sharing requirement be its tour de force or Achilles’ heel? The Regulation amounts to an ambitious and laudable step ...

The UK is a recognised powerhouse for genomic science and medicine. Genomics England’s 100,000 Genomes Project is the largest sequencing project of its kind in the world and, building on these ...

The UK government Department of Health and Social Care has released the newly updated version of the Data saves lives: reshaping health and care with data strategy for the NHS. First released in draft ...

A new type of medicine that uses an approach called ‘gene silencing’ has been approved for use in the National Health Service (NHS) in England. The medicine, patisiran (brand name Onpattro) is used ...